Loading company…
Ryne Biotechnology develops neuron replacement therapies for neurological disorders.
Ryne Biotechnology uses induced pluripotent stem cell technology to develop potential neuron replacement treatments. Its lead program, RNDP-001, targets inherited and idiopathic Parkinson’s disease; other programs address different forms of Parkinson’s disease. The company is based in San Diego, US. In February 2023, it received USD 4 million in grant funding from the California Institute for Regenerative Medicine.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in